Prospeo
Hero Section BackgroundHero Section Background
EffRx Pharmaceuticals

EffRx Pharmaceuticals Revenue

Pharmaceutical ManufacturingFlag of CHFreienbach, Schwyz, Switzerland21-50 Employees

$

EffRx Pharmaceuticals revenue & valuation

Annual revenue$4,000,000
Revenue per employee$167,000
Estimated valuation?$12,800,000
Total funding$2,300,000

Key Contacts at EffRx Pharmaceuticals

Flag of CH

Lorenzo Bosisio

Ceo

Flag of CH

Roger Iseli

National Sales Director Effrx Pharmaceuticals

Flag of CH

Nathalie Véron

Director Technical Operations And Responsible Person

Flag of CH

Mascia Ghielmetti

Director Medical Affairs

Flag of CH

Michael Schmid

International Marketing Director

Flag of CH

Christiane Sievert

Head Of Regulatory Affairs - Senior Director

Company overview

HeadquartersWolleraustrasse 41B, Freienbach, 8807, CH
Phone number+41445037860
Website
NAICS3254
SIC283
Keywords
Pharmaceuticals, Biotech, Orphan Drugs, Rare Diseases, Endocrinology, Life Cycle Management, In-Licensing, Out-Licensing, Metabolic Bone Disease / Osteoporosis, Pediatric Medications, Woda Member
Employees21-50
Socials

EffRx Pharmaceuticals Email Formats

EffRx Pharmaceuticals uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@effrx.com), used 64.7% of the time.

FormatExamplePercentage
{first name}{last name}
johndoe@effrx.com
64.7%
{first initial}{last name}
jdoe@effrx.com
35.3%

About EffRx Pharmaceuticals

EffRx Pharmaceuticals is a Swiss commercial-stage pharmaceutical company focused on the development and commercialization of musculoskeletal and rare diseases medications. EffRx’s lead commercialized product, Binosto® for the treatment of osteoporosis, is successfully commercialized by Licensees across US, European, Asian and Middle Eastern countries. The business model is centered around providing superior clinical and commercial value propositions for physicians, payers and patients. EffRx pro-actively seeks in-licensing opportunities for Europe in niche therapeutic areas, with a primary interest for rare diseases, where EffRx has received an orphan drug designation (ODD) from FDA for a pipeline asset. EffRx is a member of the World Orphan Drug Alliance (WODA - www.woda-alliance.com).

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Director
Manager
Entry

Employees by Department

EffRx Pharmaceuticals has 11 employees across 7 departments.

Departments

Number of employees

Funding Data

Explore EffRx Pharmaceuticals's funding history, including investment rounds, total capital raised, and key backers.

Funding Date
Round
Amount
Link to Article
2015-02-121$2,300,000

Funding Insights

$2,300,000

Total funding amount

$2,300,000

Most recent funding amount

1

Number of funding rounds

EffRx Pharmaceuticals Tech Stack

Discover the technologies and tools that power EffRx Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.

Site Kit

Site Kit

Analytics

Swiper

Swiper

JavaScript libraries

jQuery UI

jQuery UI

JavaScript libraries

Google Maps

Google Maps

Maps

Hello Elementor

Hello Elementor

WordPress themes

Elementor

Elementor

Page builders

Microsoft 365

Microsoft 365

Email

jQuery Migrate

jQuery Migrate

JavaScript libraries

Apache HTTP Server

Apache HTTP Server

Web servers

Twitter Emoji

Font scripts

jQuery

jQuery

JavaScript libraries

Apple iCloud Mail

Apple iCloud Mail

Webmail

Frequently asked questions

EffRx Pharmaceuticals is located in Freienbach, Schwyz, CH.
You can reach EffRx Pharmaceuticals at +41445037860.
EffRx Pharmaceuticals generates an estimated annual revenue of $4,000,000. This revenue figure reflects the company's market position and business performance in its industry.
EffRx Pharmaceuticals has an estimated valuation of $12,800,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
EffRx Pharmaceuticals has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.
EffRx Pharmaceuticals has raised a total of $2,300,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles